Real-time enrollment status for this netherton syndrome clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 5:37 PM UTC
| NCT Number | NCT06953466 |
| Recruiting Status | Recruiting |
| Condition | Netherton Syndrome |
| Phase | PHASE2 |
| Target Enrollment | 8 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Quoin Pharmaceuticals |
| Last Updated on CT.gov | July 20, 2025 (Jul 20, 2025) |
As of July 20, 2026: Clinical trial NCT06953466 is currently recruiting participants. This phase2 study for netherton syndrome is actively seeking new participants at 1 location across the United States. The study is sponsored by Quoin Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06953466 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06953466 was last updated Jul 20, 2025 (July 20, 2025). HelloStudys verifies this status automatically.